Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure
Xconomy
JULY 18, 2016
Evoke’s late-stage study failed to show a significant benefit to the drug, EVK-001, versus placebo at all 41 of the sites that tested it nationally. Actavis is now known as Allergan (NYSE: AGN ), adopting the name following its acquisition of that company last year. Metoclopramide is currently available in oral and intravenous forms.
40 
Let's personalize your content